{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:49:48Z","timestamp":1760820588195},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/olq.0000000000000073","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T21:50:08Z","timestamp":1389304208000},"page":"133-136","source":"Crossref","is-referenced-by-count":12,"title":["Provider Characteristics Associated With Guideline-Nonadherent Gonorrhea Treatment, Massachusetts, 2010"],"prefix":"10.1097","volume":"41","author":[{"given":"Jennifer","family":"Swails","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Smock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-12-20210213","first-page":"579","article-title":"A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: How much really is known Sex Transm D","volume":"28","author":"Rottingen","year":"2001","journal-title":"is"},{"key":"R4-12-20210213","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat ofuntreatable gonococcal infection.","volume":"366","author":"Bolan","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-12-20210213","first-page":"332","article-title":"Update to CDCs sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections.","volume":"56","year":"2007","journal-title":"MMWR"},{"key":"R6-12-20210213","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2011.300283","article-title":"Changes in fluoroquinolone use for gonorrhea following publication of revised treatment guidelines.","volume":"102","author":"Dowell","year":"2012","journal-title":"Am J Public Health"},{"key":"R7-12-20210213","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010.","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"R8-12-20210213","first-page":"590","article-title":"Update to CDCs sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections.","volume":"61","year":"2012","journal-title":"MMWR"},{"key":"R9-12-20210213","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/OLQ.0b013e3181c53363","article-title":"A closer look at age: deconstructing aggregate gonorrhea and chlamydia rates, California, 1998-2007.","volume":"37","author":"Jacobs","year":"2010","journal-title":"Sex Transm Dis"},{"key":"R10-12-20210213","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea Detailed characterization of the first strain with high-level resistance to ceftriaxone.","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-12-20210213","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in Europe (France): Novel penA mosaic allele in a successful international clone causes treatment failure.","volume":"56","author":"Unemo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-12-20210213","doi-asserted-by":"crossref","first-page":"ii","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010.","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"R13-12-20210213","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.eimc.2011.11.010","article-title":"First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011.","volume":"30","author":"Carnicer-Pont","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R15-12-20210213","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why dont physicians follow clinical practice guidelines A framework for improvement.","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0000000000000073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T22:10:40Z","timestamp":1647987040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201402000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0000000000000073","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}